TQB2102 Injection

· Chia Tai Tianqing Pharmaceutical Group; Nanjing Shunxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB2102 Injection, covering 2025-08-01 to 2025-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers [Phase 1]